Are you Dr. Kummar?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 18 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3181 SW Sam Jackson Park Rd
Portland, OR 97239Phone+1 503-314-7168
Summary
- Dr. Shivaani Kummar, MD is an oncologist in Portland, Oregon. She is currently licensed to practice medicine in Oregon, California, and Connecticut. She is affiliated with OHSU Hospital.
Education & Training
Lady Hardinge Medical CollegeClass of 1995
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology
Certifications & Licensure
CA State Medical License 2014 - 2026
OR State Medical License 2020 - 2025
MD State Medical License 1996 - 2018
CT State Medical License 2000 - 2004- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy) Start of enrollment: 2015 Jan 01
Publications & Presentations
PubMed
- First-in-human study of 23ME-00610, an antagonistic antibody for genetically validated CD200R1 immune checkpoint, in participants with advanced solid malignancies.Shivaani Kummar, Albiruni Abdul Razak, Scott Laurie, Dylan M Glatt, Sariah Kell
Cancer Research Communications. 2024-12-09 - Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancer.Apostolia M Tsimberidou, Farah A Alayli, Kwame Okrah, Alexandra Drakaki, Danny N Khalil
The Journal of Experimental Medicine. 2024-10-07 - Uncovering therapeutic targets for macrophage-mediated T cell suppression and PD-L1 therapy sensitization.Sushil Kumar, Dhanir Tailor, Arpit Dheeraj, Wenqi Li, Kirsten Stefan
Cell Reports. Medicine. 2024-09-17
Press Mentions
AACR Annual Meeting 2023: Phase III Immunotherapy Trials Offer Hope for Patients with Lung, Liver, and Biliary Tract CancersMay 4th, 2023- The Topic of CancerJune 16th, 2022
- OHSU Expands Capacity for Cancer Clinical TrialsAugust 25th, 2021
- Join now to see all
Professional Memberships
- Member
